BNTC Share Price Performance
US$14.20
4.94 (53.35%)
Price US$14.20
Share PriceUS$14.20
Companies Like Benitec Biopharma (NASDAQ:BNTC) Can Afford To Invest In Growth
May 29
Benitec Biopharma Inc. Stock Price
- 0 Narratives written by author
- 0 Comments on narratives written by author
- 3 Fair Values set on narratives written by author
BNTC Community Narratives
There are no narratives available yet.
Recent BNTC News & Updates
Benitec Biopharma Inc. Key Details
Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
n/a
- Earnings per share (EPS)
- -1.44
- Gross Margin
- 0%
- Net Profit Margin
- 0%
- Debt/Equity Ratio
- 0%
Benitec Biopharma Inc. Competitors
Snowflake Analysis
About BNTC
- Founded
- n/a
- Employees
- 19
- CEO
- WebsiteView website
Benitec Biopharma Inc., a clinical-stage biotechnology company, focuses on the development of novel genetic medicines. Its Silence and Replace, a DNA-directedRNA interference platform combines RNA interference with gene therapy to create medicines that simultaneously facilitate sustained silencing of disease-causing genes and concomitant delivery of wildtype replacement genes following a single administration of the therapeutic construct. The company is developing BB-301, an AAV-based gene therapy designed to silence the expression of the disease-causing gene for the treatment of oculopharyngeal muscular dystrophy related dysphagia. Benitec Biopharma Inc. is headquartered in Hayward, California.
Market Insight
Rare earths may be a sliver of the global metals market, but they punch far above their weight. These obscure elements are the invisible wiring of modern life.
Continue reading
U.S. Market Performance
- 7 Days: 0.8%
- 3 Months: 8.3%
- 1 Year: 17.8%
- Year to Date: 15.4%
Over the last 7 days, the market has remained flat, although notably the Utilities sector gained 3.1% in that time. More promisingly, the market is up 18% over the past year. Looking forward, earnings are forecast to grow by 15% annually. Market details ›